Life and times of leading cardiologists with Rob Califf. Guest: Salim Yusuf
February 16, 2011
Recorded: November 15, 2010

Dr Robert Califf conducts a series of in-depth and personal interviews with his peers in the world of cardiology to find out what makes them tick, how they feel about the future, and what lessons they have learned during their exceptional careers.

From modest origins in the village of Kottarakara in Kerala, India, through to international recognition as a top clinical trialist, thinker, and leader in heart disease and population health, Dr Salim Yusuf's exceptional career has shaped the field of research and clinical practice for the past three decades. Learn about Dr Yusuf's early life in India, his Rhodes Scholarship and studies at Oxford, and why he expresses eternal gratitude to his early mentors, Peter Sleight and Richard Peto. In this insightful interview, Dr Yusuf talks for the first time in public about his bout with cancer, his drive to overcome life's obstacles, and the calling that led him to North America—first to the US National Institutes of Health and then to clinical research and academia at McMaster University in Hamilton, ON.


Robert M Califf MD
Professor of Medicine
Donald F Fortin Professor, Cardiology
Vice Chancellor for Clinical Research
Director, Duke Translational
Medicine Institute
Duke University Medical Center
Durham, NC

To view Dr Califf's conflict of interest statement, click here.

Salim Yusuf MD DPhil MRCP
Heart and Stroke Foundation Chair in Cardiology
Professor, Department of Medicine
Joint Member, Department of Clinical Epidemiology and Biostatistics
Director, Population Health Research Institute
McMaster University
Faculty of Health Sciences
Hamilton Health Sciences Corporation
McMaster Clinic
Hamilton, ON

Dr Yusuf has served as an advisor, consultant, speaker or member of a speaker's bureau for Sanofi-Aventis, Bristol-Myers Squibb, Boehringer Ingelheim, and Servier. He has received grants for clinical research from Sanofi-Aventis, Bristol-Myers Squibb, Boehringer Ingelheim, and Servier.

Related Links: Also in the series: